Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U74899DL1988PTC033151 Incorporated 13 September 1988 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹437.53 Cr
▼ 5.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹96 Lakh
Issued & subscribed
Open charges
₹54.85 Cr
Satisfied ₹25.3 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
349
Latest available

About Copmed Pharmaceuticals Private Limited

Data last updated: 31 December 2025

Copmed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mankind Pharma Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 September 1988, the company has been in operation for over 38 years.

Registered with ROC Delhi under CIN U74899DL1988PTC033151.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹96 Lakh. It is led by directors including Abhay Kumar Srivastava and Akhlas Ahmed.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 208 Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020.

As per the financials filed for FY 2025, the company reported a revenue of ₹437.53 Cr, a decline of 5% compared to the previous year.

The company has a workforce of approximately 349 employees as per the latest available data. It operates as a subsidiary of Mankind Pharma Limited.

The company is associated with 1 brand - Copmed Pharmaceuticals. As per MCA filings, the company has open charges of ₹54.85 Cr and satisfied charges of ₹25.3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website copmedpharma.com.

Company Details of Copmed Pharmaceuticals Private Limited
CIN U74899DL1988PTC033151
Registration Number 033151
Incorporation Date 13 September 1988
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Mankind Pharma Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    208 Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020
  • Industry
    Pharma, Drug Formulation & Development
Company report
Copmed Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Copmed Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Copmed Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited operates one associated brand: Copmed Pharmaceuticals. These brands represent Copmed Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. copmedpharma.com

Competitors & Alternatives of Copmed Pharmaceuticals Private Limited

Brands and companies operating in the same space as Copmed Pharmaceuticals Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited is engaged in principal business activities including manufacturing and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, scientific research and development. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Copmed Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited is audited by S.R. Batliboi & Co. LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S.R. Batliboi & Co. LLP Locked Locked Locked
Premium access

Complete auditor history for Copmed Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited is currently managed by 6 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Abhay Kumar Srivastava Director 01 Mar 2021 5 Years 5 Months Current
Akhlas Ahmed Director 01 Mar 2021 5 Years 5 Months Current
Veer Singh Pal Director 31 Jul 2009 17 Years 0 Months Current
Jagmohan Sharma Whole-Time Director 08 Aug 2024 2 Years 0 Months Current
Bhupendra Kaushik Director 26 Mar 2021 5 Years 4 Months Current
Anju Kumari Jha Director 26 Mar 2021 5 Years 4 Months Current

Financials of Copmed Pharmaceuticals Private Limited FY 2025 filings available

Copmed Pharmaceuticals Private Limited reported revenue of ₹437.53 Cr (down 5.00% YoY) for FY 2025.

Revenue · FY 2025
₹437.53 Cr ▼ 5.00%
Premium access

Ten-year financial statements for Copmed Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Copmed Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Copmed Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Copmed Pharmaceuticals Private Limited

Open charges
₹54.85 Cr
Satisfied charges
₹25.3 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹54.00 Cr
Others₹0.85 Cr
Latest charge details
DateLenderAmountStatus
22 Sep 2021 Others ₹39.78 Lakh Open
22 Sep 2021 Others ₹45.31 Lakh Open
30 Sep 2010 Hdfc Bank Limited ₹54 Cr Open
30 Sep 2010 Hdfc Bank Limited ₹20 Cr Satisfied
05 Sep 2009 Member Secretary ₹30 Lakh Satisfied

Total charge records: 6 View all charges

Employees and EPFO Compliance at Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited has a workforce of 349 employees as of May 21, 2025.

Employee count
349
Active EPFO establishments
2
Employee growth
0.29%
Premium access

Employee and EPFO history for Copmed Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Copmed Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Copmed Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Copmed Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Copmed Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Copmed Pharmaceuticals Private Limited

Premium access

MSME payment history for Copmed Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Copmed Pharmaceuticals Private Limited

Premium access

Corporate group structure for Copmed Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Copmed Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Copmed Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Copmed Pharmaceuticals Private Limited

Activity
30 Sep 2025
Copmed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Copmed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Directors
08 Aug 2024
Jagmohan Sharma was appointed as a Whole-time director on 08 Aug 2024 & has been associated with this company since 2 years 17 days.
Charges
08 May 2023
A charge with Hdfc Bank Limited of Rs. 54.00 Cr registered on 30 Sep 2010 with Charge ID 10248378 was modified on 08 May 2023.
Charges
05 Oct 2021
A charge registered on 30 Sep 2010 via Charge ID 10248381 with Hdfc Bank Limited was fully satisfied on 05 Oct 2021.
Charges
22 Sep 2021
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100481953 was registered on 22 Sep 2021.

Frequently Asked Questions about Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 13 September 1988 (38+ years old) and is registered under CIN U74899DL1988PTC033151. The company has 349 employees.

Copmed Pharmaceuticals Private Limited reported revenue of ₹437.53 Cr for FY 2025 (down 5.00% YoY).

The current directors of Copmed Pharmaceuticals Private Limited are:

The primary industry of Copmed Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Copmed Pharmaceuticals Private Limited can be reached at the registered office: 208 Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020, or through the website copmedpharma.com.

The authorised capital is ₹2 Cr, and the paid-up capital is ₹96 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available